 | Royalty Pharma plc | |||
| NMS : RPRX || Location: United States | ||||
$28.16+0.27 (+0.97%) |
1.78 M | 27.69 - 28.19 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 12.391 M |
| March 15, 2024 | 12.648 M |
| Feb. 29, 2024 | 13.128 M |
| Feb. 15, 2024 | 11.498 M |
| Jan. 31, 2024 | 10.280 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | 1.03 | 1.15 | 11.63% |
| 09/30/2023 | 0.77 | 0.79 | 2.45% |
| 06/30/2023 | 0.82 | 0.84 | 1.92% |
| 03/31/2023 | 1.30 | 1.60 | 23.19% |
| 12/31/2022 | 1.50 | 1.56 | 3.87% |
Recent Dividends
| Div Date | Div Amount |
|---|---|
| 02/15/2024 | 0.21 |
| 11/16/2023 | 0.20 |
| 08/17/2023 | 0.20 |
| 05/18/2023 | 0.20 |
| 02/15/2023 | 0.20 |
RPRX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 446.692M | Shares Float | 383.820M |
| Short Float | 12.391M | Market Cap | 12458.24M |
| Institution ownership | 72.10% | Insider ownership | 3.827% |
| Earnings Date | 05/02/2024 AMC | Cash Per Share | ? |
| Trailing EPS | 2.53 | Forward EPS | 4.14 |